Polypoidal Choroidal Vasculopathy: Clinical Trials

1 trial for Polypoidal Choroidal Vasculopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy
Bevacizumab (tradename: Avastin) - Choroidal Neovascularisation, Polypoidal Choroidal Vasculopathy
Phase 3UnknownSingapore National Eye Centre502006-06-012007-09-26

Narrower conditions

Choroidal Neovascularization (1)

Broader conditions

Choroid Diseases (1)  ·  Eye Diseases (1)  ·  Metaplasia (1)  ·  Neovascularization, Pathologic (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Uveal Diseases (1)

Interventions

Bevacizumab (1)

Sponsors

Singapore National Eye Centre (1)

Top investigators

Chong-Lye Ang, FRCOphth (1)